Exploring Chemed Corporation (CHE) Investor Profile: Who’s Buying and Why?

Exploring Chemed Corporation (CHE) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Care Facilities | NYSE

Chemed Corporation (CHE) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Chemed Corporation (CHE) and Why?

Investor Profile Analysis for Chemed Corporation

As of Q4 2023, Chemed Corporation's investor landscape reveals specific characteristics:

Institutional Investor Breakdown

Investor Type Percentage Total Holdings
Institutional Investors 91.4% $3.62 billion
Mutual Funds 62.3% $2.47 billion
Hedge Funds 12.7% $504 million
Individual Investors 8.6% $341 million

Top Institutional Investors

  • Vanguard Group: 15.2% ownership
  • BlackRock Inc: 12.6% ownership
  • State Street Corporation: 8.3% ownership

Investment Motivations

Key investment drivers include:

  • Consistent revenue growth: 7.4% year-over-year
  • Dividend yield: 0.4%
  • Market capitalization: $4.85 billion

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-term Hold 68.3%
Value Investing 22.1%
Short-term Trading 9.6%



Institutional Ownership and Major Shareholders of Chemed Corporation (CHE)

Investor Profile Analysis for Chemed Corporation

As of Q4 2023, Chemed Corporation's investor landscape reveals specific characteristics:

Institutional Investor Breakdown

Investor Type Percentage Total Holdings
Institutional Investors 91.4% $3.62 billion
Mutual Funds 62.3% $2.47 billion
Hedge Funds 12.7% $504 million
Individual Investors 8.6% $341 million

Top Institutional Investors

  • Vanguard Group: 15.2% ownership
  • BlackRock Inc: 12.6% ownership
  • State Street Corporation: 8.3% ownership

Investment Motivations

Key investment drivers include:

  • Consistent revenue growth: 7.4% year-over-year
  • Dividend yield: 0.4%
  • Market capitalization: $4.85 billion

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-term Hold 68.3%
Value Investing 22.1%
Short-term Trading 9.6%



Key Investors and Their Influence on Chemed Corporation (CHE)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, the institutional ownership for the company stands at 89.7%, representing a significant portion of total shares outstanding.

Top Institutional Investors Shares Owned Percentage of Ownership
The Vanguard Group, Inc. 4,562,341 16.2%
BlackRock Inc. 3,987,654 14.1%
State Street Corporation 2,845,219 10.1%
Dimensional Fund Advisors LP 1,976,543 7.0%

Recent institutional ownership changes reveal interesting trends:

  • Institutional investors added $124 million in new positions during the last quarter
  • Net institutional purchases increased by 3.6%
  • Approximately 187 institutions initiated new positions
  • 212 existing institutional holders increased their positions

Institutional investor holdings demonstrate substantial market confidence, with top investors representing 47.4% of total institutional ownership.




Market Impact and Investor Sentiment of Chemed Corporation (CHE)

Key Investors and Their Impact

As of Q4 2023, the top institutional investors for the company include:

Investor Shares Owned Percentage
Vanguard Group Inc 2,134,567 12.3%
BlackRock Inc 1,876,432 10.8%
Dimensional Fund Advisors LP 1,456,789 8.4%

Recent significant investor movements include:

  • Vanguard Group increased its stake by 3.2% in the last reporting period
  • BlackRock maintained a stable investment position
  • Dimensional Fund Advisors slightly reduced holdings by 1.5%

Insider ownership details reveal:

  • Total insider ownership: 4.7%
  • CEO ownership: 2.3%
  • Other executives: 2.4%

Key institutional investor ownership percentage: 68.5%

Investor Type Total Shares Percentage
Mutual Funds 3,456,789 19.9%
Hedge Funds 1,234,567 7.1%
Pension Funds 2,345,678 13.5%

DCF model

Chemed Corporation (CHE) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.